NCT03359681View on ClinicalTrials.gov

Metformin Treatment for Colon Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

September 2, 2021

Study Completion Date

October 4, 2021

Conditions
Colon Cancer
Interventions
DRUG

Metformin Hydrochloride

metformin 500mg three times a day 20 days before colon cancer surgery and 10 days after.

DRUG

Placebo oral capsule

placebo 500mg three times a day 20 days before colon cancer surgery and 10 days after.

Trial Locations (1)

4200

Department of Surgery, Slagelse Hospital, Slagelse

All Listed Sponsors
lead

Zealand University Hospital

OTHER

NCT03359681 - Metformin Treatment for Colon Cancer | Biotech Hunter | Biotech Hunter